Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (otvorí nové okno)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Zdroj‎: Ann Surg 2019;269(5):794-804.

Označenie‎: PubMed 30418206

Identifikátor digitálneho objektu‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (otvorí nové okno)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (otvorí nové okno)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Zdroj‎: Ir Med J 2018;111(4):730.

Označenie‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (otvorí nové okno)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (otvorí nové okno)

Kotzé A, Carter LA, Scally AJ.

Zdroj‎: Br J Anaesth 2012;108(6):943-52.

Označenie‎: PubMed 22593128

Identifikátor digitálneho objektu‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (otvorí nové okno)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (otvorí nové okno)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Zdroj‎: Blood Transfus 2014;12(1):40-9.

Označenie‎: PubMed 24120595

Identifikátor digitálneho objektu‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (otvorí nové okno)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (otvorí nové okno)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Zdroj‎: Int Orthop 2019;43(1):39-46.

Označenie‎: PubMed 30232527

Identifikátor digitálneho objektu‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (otvorí nové okno)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (otvorí nové okno)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Zdroj‎: J Arthroplasty 2020;35(11):3084-8.

Označenie‎: PubMed 32654943

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (otvorí nové okno)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (otvorí nové okno)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Zdroj‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Označenie‎: PubMed 24196467

Identifikátor digitálneho objektu‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (otvorí nové okno)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (otvorí nové okno)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Zdroj‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Označenie‎: PubMed 24196466

Identifikátor digitálneho objektu‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (otvorí nové okno)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (otvorí nové okno)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Zdroj‎: Spine 2009;34(19):2096-103.

Označenie‎: PubMed 19730217

Identifikátor digitálneho objektu‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (otvorí nové okno)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (otvorí nové okno)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Zdroj‎: J Orthop Surg 2017;25(1):2309499016684725.

Označenie‎: PubMed 28176599

Identifikátor digitálneho objektu‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (otvorí nové okno)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (otvorí nové okno)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Zdroj‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Označenie‎: PubMed 24034510

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (otvorí nové okno)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (otvorí nové okno)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Zdroj‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Označenie‎: PubMed 23138237

Identifikátor digitálneho objektu‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (otvorí nové okno)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (otvorí nové okno)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Zdroj‎: J Knee Surg 2017;30(5):460-6.

Označenie‎: PubMed 27699724

Identifikátor digitálneho objektu‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (otvorí nové okno)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (otvorí nové okno)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Zdroj‎: J Arthroplasty 2017;32(8):2375-80.

Označenie‎: PubMed 28343823

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (otvorí nové okno)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (otvorí nové okno)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Zdroj‎: Am J Orthop 2016;45(7):E439-43.

Označenie‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (otvorí nové okno)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (otvorí nové okno)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Zdroj‎: Orthop Clin North Am 2017;48(2):109-15.

Označenie‎: PubMed 28336035

Identifikátor digitálneho objektu‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (otvorí nové okno)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (otvorí nové okno)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Zdroj‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Označenie‎: PubMed 26652697

Identifikátor digitálneho objektu‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (otvorí nové okno)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (otvorí nové okno)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Zdroj‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Označenie‎: PubMed 34570739

Identifikátor digitálneho objektu‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (otvorí nové okno)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (otvorí nové okno)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Zdroj‎: Orthopedics 2017;40(6):e1044-9.

Označenie‎: PubMed 28968480

Identifikátor digitálneho objektu‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (otvorí nové okno)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (otvorí nové okno)

Harris RN, Moskal JT, Capps SG.

Zdroj‎: J Arthroplasty 2015;30(2):192-5.

Označenie‎: PubMed 25534861

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (otvorí nové okno)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (otvorí nové okno)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Zdroj‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Označenie‎: PubMed 22854336

Identifikátor digitálneho objektu‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (otvorí nové okno)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (otvorí nové okno)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Zdroj‎: Bone Jt Open 2022;3(7):536-42.

Označenie‎: PubMed 35816170

Identifikátor digitálneho objektu‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (otvorí nové okno)

Cost-benefit analysis of the use of tranexamic acid in total replacement hip surgery. (otvorí nové okno)

Lopez-Picado A, Barrachina B, Remón M, Errea M.

Zdroj‎: J Clin Anesth 2019;57:124-8.

Označenie‎: PubMed 30999196

Identifikátor digitálneho objektu‎: 10.1016/j.jclinane.2019.04.006

https://www.ncbi.nlm.nih.gov/pubmed/30999196 (otvorí nové okno)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (otvorí nové okno)

Moskal JT, Harris RN, Capps SG.

Zdroj‎: J Arthroplasty 2015;30(3):365-8.

Označenie‎: PubMed 25458093

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (otvorí nové okno)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (otvorí nové okno)

Örs Ç, Çaylak R.

Zdroj‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Označenie‎: PubMed 34730529

Identifikátor digitálneho objektu‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (otvorí nové okno)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (otvorí nové okno)

Phan DL, Ani F, Schwarzkopf R.

Zdroj‎: J Arthroplasty 2016;31(3):579-82.

Označenie‎: PubMed 26601635

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (otvorí nové okno)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (otvorí nové okno)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Zdroj‎: Transfusion 2016;56(2):466-71.

Označenie‎: PubMed 26509250

Identifikátor digitálneho objektu‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (otvorí nové okno)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (otvorí nové okno)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Zdroj‎: BMJ 2014;349:g4829.

Označenie‎: PubMed 25116268

Identifikátor digitálneho objektu‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (otvorí nové okno)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (otvorí nové okno)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Zdroj‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Označenie‎: PubMed 20063079

Identifikátor digitálneho objektu‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (otvorí nové okno)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (otvorí nové okno)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Zdroj‎: J Arthroplasty 2018;33(7):2092-9.e9.

Označenie‎: PubMed 29605152

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (otvorí nové okno)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (otvorí nové okno)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Zdroj‎: Int Orthop 2019;43(12):2707-14.

Označenie‎: PubMed 30671601

Identifikátor digitálneho objektu‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (otvorí nové okno)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (otvorí nové okno)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Zdroj‎: J Arthroplasty 2014;29(8):1512-5.

Označenie‎: PubMed 24630599

Identifikátor digitálneho objektu‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (otvorí nové okno)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (otvorí nové okno)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Zdroj‎: Thromb Res 2018;171:143-8.

Označenie‎: PubMed 30312799

Identifikátor digitálneho objektu‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (otvorí nové okno)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (otvorí nové okno)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Zdroj‎: Medicine 2017;96(52):e9552.

Označenie‎: PubMed 29384974

Identifikátor digitálneho objektu‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (otvorí nové okno)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (otvorí nové okno)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Zdroj‎: Spine J 2017;17(7):977-82.

Označenie‎: PubMed 28323241

Identifikátor digitálneho objektu‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (otvorí nové okno)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (otvorí nové okno)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Zdroj‎: J Orthop Surg Res 2014;9:50.

Označenie‎: PubMed 24997589

Identifikátor digitálneho objektu‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (otvorí nové okno)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (otvorí nové okno)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Zdroj‎: Transfusion 2017;57(2):357-66.

Označenie‎: PubMed 28019009

Identifikátor digitálneho objektu‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (otvorí nové okno)

Cell saver for adult spinal deformity surgery reduces cost. (otvorí nové okno)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Zdroj‎: Spine Deform 2017;5(4):272-6.

Označenie‎: PubMed 28622903

Identifikátor digitálneho objektu‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (otvorí nové okno)